In vitro effect of lung surfactant on alveolar macrophage defence mechanisms against Cryptococcus neoformans

Mycopathologia

Volumn 144, Issue 1, 1998, Pages 21-27

  Gross, N T ^a,b   Camner, P ^c   Chinchilla, M ^b   Jarstrand, C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alveolar macrophages; Antibody; Cryptococcus neoformans; Lung surfactant

Indexed keywords

BIOLOGICAL PRODUCT; FUNGUS ANTIBODY; IMMUNOGLOBULIN G; LUNG SURFACTANT; NITROBLUE TETRAZOLIUM; OPSONIN; PHOSPHOLIPID; PORACTANT;

ANIMAL; ARTICLE; BIOSYNTHESIS; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LUNG; LUNG ALVEOLUS MACROPHAGE; METABOLISM; OXIDATION REDUCTION REACTION; PHAGOCYTOSIS; RABBIT; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES, FUNGAL; BIOLOGICAL PRODUCTS; CRYPTOCOCCUS NEOFORMANS; IMMUNOGLOBULIN G; LUNG; MACROPHAGES, ALVEOLAR; NITROBLUE TETRAZOLIUM; OPSONIN PROTEINS; OXIDATION-REDUCTION; PHAGOCYTOSIS; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032459131     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006948825384     Document Type: Article

References (32)

1. Dupont B, Graybill J, Armstrong D, Laroche R, Touzé JE, Wheat LJ. Fungal infections in AIDS patients. J Med Vet Mycol 1992; 30(Suppl. 1): 19-28.
2. Berstein B, Flomenberg P, Letzer D. Disseminated cryptococcal disease complicating steroid therapy for Pneumocystis carinii pneumonia in a patient with AIDS. South Med J 1994; 87: 537-538.
3. White M, Armstrong D. Cryptococcosis. Infec Dis Clin North Am 1994; 8: 383-398.
4. Allen J, Moore S, Pope-Harman A, Marsh C, Wewers M. Immunosuppresive properties of surfactant and plasma on alveolar macrophages. J Lab Clin Med 1995; 125: 356-369.
5. Davis-Scibienski C, Beaman BL. Interaction of alveolar macrophages with Nocardia asteroides: Immunological enhancement of phagocytosis, phagosome-lysosome fusion, and microbicidal activity. Infect Immun 1980; 30: 578-587.
6. Jarstrand C, Berggren P, Curstedt T, Johansson A, Robertson B, Wiernik A. Influence of lung surfactant phospholipids on neutrophilic granulocytes and blood monocytes. Prog Respir Res 1984; 18:44-50.
7. O'Neill S, Lesperance E, Klas D. Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages. Am Rev Respir Dis 1984; 130: 225-230.
8. Herting E, Sun B, Jarstrand C, Curstedt T, Robertson B. Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimental induced neonatal group B streptococcal pneumonia. Arch Dis Child 1997; 76: F3-F8.
9. Walti H, Polla B, Bachelet M. Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediator released by resting and stimulated human monocyte. Pediatr Res 1997; 41: 114-119.
10. Rose R, Catalano P, Koziel H, Furlong S. Abnormal lipid composition of bronchoalveolar lavage fluid obtained from individuals with AIDS-related lung disease. Am J Respir Crit Care Med 1994; 149: 332-338.
11. Bolanos B, Mitchell T. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol 1989; 27: 203-217.
12. Kozel T. Opsonization and phagocytosis of Cryptococcus neoformans. Arch Med Res 1993; 24: 211-218.
13. Levitz S. Macrophage-Cryptococcus interactions. Immunol Ser 1994; 60: 533-543.
14. Gross NT, Chinchilla M, Camner P, Jarstrand C. Anticryptococcal activity by alveolar macrophages from rats treated with cortisone acetate during different periods of time. Mycopathologia 1996; 136: 1-8.
15. Nessa K, Gross NT, Jarstrand C, Johansson A, Camner P. In vivo interaction between alveolar macrophages and Cryptococcus neoformans. Mycopathologia 1997; 139: 1-7.
16. Gross NT, Nessa K, Camner P, Chinchilla M, Jarstrand C. Interaction between Cryptococcus neoformans and alveolar macrophages. J Med Vet Mycol 1997; 35: 263-269.
17. Sanford JE, Lupan DM, Schlagetter AM, Kozel TR. Passive immunization against Cryptococcus neoformans with an isotype-swith family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect Immun 1990; 58: 1919-1923.
18. Gan X, Jarstrand C, Herting E, Robertson B. Surfactant-borne antibody against encapsulated bacteria causing pneumonia in neonates and older children. Biol Neonate 1997; 71 (Suppl. 1): 67.
19. Nyberg K, Nessa K, Johansson A, Jarstrand C, Camner P. Alveolar macrophage response to yeast and inert particles. J Med Vet Mycol 1996; 34: 11-17.
20. Robertson B, Curstedt T, Johansson J, Jörnvall H, Kobayashi T. Structural and functional characterization of porcine surfactant isolated by liquid-gel chromatography. Prog Resp Res 1990; 25: 237-246.
21. Hed, J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested microorganism in phagocytosis. FEMS Microbiol Lett 1977; 1: 357-361.
22. Levitz SM, DiBenedetto DJ. Differential stimulation of murine peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect Immun 1989; 56: 2544-2551.
23. Jarstrand C, Lundborg M, Wernik A, Camner P. Alveolar macrophage function in nickel dust exposed rabbits. Toxicology 1978; 11: 353-359.
24. Mody C, Tyler C, Sitrin R, Jackson C, Toews G. Interferon-γ activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol 1991; 5: 19-26.
25. Zelings B, Nerurkar L, Bellanti J. Chemotactic and candidacidal responses of rabbit alveolar macrophages during postnatal development and the modulating roles of surfactant in these responses. Infect Immun 1984; 44: 379-385.
26. Speer CP, Götze B, Curstedt T, Robertson B. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res 1991; 30: 69-74.
27. Schroit A, Gallily R. Macrophage fatty acid composition and phagocytosis: effect of unsaturation on cellular phagocytic activity. Immunology 1979; 36: 199-205.
28. Wiernik A, Jarstrand C, Julander I. The effect of intralipid on mononuclear and polymorphonuclear phagocytes. Am J Clin Nutr 1983; 37: 256-261.
29. Hayakawa H, Myrvik Q, St. Clair R. Pulmonary surfactant inhibits priming of rabbit alveolar macrophage. Evidence that surfactant supresses the oxidative burst of alveolar macrophages in infant rabbits. Am Rev Respir Dis 1989; 140: 1390-1397.
30. Schrod L, Hornemann F, von Stockhausen H. Chemiluminescence activity of phagocytes from tracheal aspirates of premature infants after surfactant therapy. Acta Pediatr 1996; 85: 719-723.
31. Manson R, Stossel T, Vaughan M. Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles. J Clin Invest 1972; 51: 2399-2407.
32. Jacobs A, Paul B, Strauss R, Sbarra A. The role of the phagocyte in host-parasite interactions. XXIII. Relation of bactericidal activity to peroxidase-associated decarboxylation and deamination. Biochem Biophys Res Commun 1970; 39: 284-289.